1217 results found
The Research Involving Human Embryos Act 2002 requires that research on human embryos can only be conducted under a licence issued by the National Health and Medical Research Council (NHMRC) Embryo Research Licensing Committee (NHMRC Licensing Committee).
At NHMRC, we aim to create a workplace which supports all staff, regardless of their gender, age, cultural or religious background, sexual orientation or personal attributes. We want NHMRC to be a flexible and fair work environment, in which staff can flourish and where differences between employees are respected and viewed as an organisational asset.
10 of the Best research projects 2012 showcases 10 Australian health and medical research projects chosen from among the thousands of NHMRC-funded medical research projects in Australia.
As a recommended action under NHMRC’s Road Map 3: A strategic framework for improving Aboriginal and Torres Strait Islander health through research and associated Action Plan 2021–2024 Triennium, a review of the Indigenous Research Excellence Criteria (IREC) was undertaken in 2023. This included national consultation with the feedback considered by the Principal Committee Indigenous Caucus (PCIC) and a consultation report released in December 2023.
In providing a safe and healthy workplace, we provide an environment in which we can all effectively contribute to achieving community and business outcomes.
Information for MRFF grant holders submitting progress, final and additional reports on grant outcomes.
The Clinical Practice Guidelines for the management of overweight and obesity in adults, adolescents and children in Australia is intended for use by clinicians including general practitioners.
A useful guide explaining key terms used in embryo research. Provides definitions of the main terms used, including biological definitions and therapy explanations.
Clinician researchers are health professionals engaged in both patient care and research. As such, they are uniquely placed to provide insights into their clinical practice and research, implementing evidence-based, best practice for their patients, and addressing clinically relevant problems through research. The Health Translation Advisory Committee (HTAC) and the National Health and Medical Research Council (NHMRC) have previously explored concerns related to clinician researcher career pathways through a research project undertaken by ORIMA Research in 20191; however only 1% of research respondents identified as Aboriginal or Torres Strait Islander. As such, the NHMRC’s Principal Committee Indigenous Caucus (PCIC) and HTAC identified the need to undertake a project specifically with Aboriginal and Torres Strait Islander clinician researchers, to better understand their specific career experiences, enablers and barriers, as well as supports required to attract and retain this audience as clinician researchers.
The Peer Review Analysis Committee was established on 1 October 2020 under section 39 of the National Health and Medical Research Council Act 1992, to advise the NHMRC CEO on aspects of the peer review process.
The Privacy Legislation Amendment Act 2006 (Cth) made changes to the Privacy Act 1988(Cth) (the Privacy Act) to allow health practitioners to disclose patient’s genetic information, whether or not they give consent, in circumstances where there is reasonable belief that doing so is necessary to lessen or prevent a serious threat to the life, health or safety of their genetics relative(s). The amendments do not oblige disclosure of information but provide the framework for this to occur under the appropriate circumstances.
10 of the Best NHMRC research projects – Thirteenth Edition describes 10 Australian health and medical research projects chosen from among the thousands of NHMRC-funded medical research projects underway in Australia.
The Australian Government commissioned a review of the clinical effectiveness of 16 natural therapies excluded from private health insurance rebates in April 2019. The Department of Health and Aged Care engaged National Health and Medical Research Council (NHMRC) to assist in its review by commissioning evidence evaluations that assessed published scientific research on the excluded therapies. NHMRC completed its role in the Natural Therapies Review 2024 with submission of all finalised evidence evaluations to the Department of Health and Aged Care in January 2025.
We provide resources to assist researchers and members of animal ethics committees (AECs) to consider the ethical and welfare issues about the use of genetically modified and cloned animals.
The translation of health and medical research provides the best opportunity for populations to receive excellent health care and drive advances and breakthroughs in health care in Australia.